Estado actual del diagnóstico y tratamiento de la trombocitopenia inducida por heparina (TIH)
Authors:
Open Access
- 24 July 2021
- journal article
- research article
- Published by Elsevier in Medicina Clinica
- Vol. 158 (2) , 82-89
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trialCritical Care, 2015
- Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort studyBlood, 2015
- Heparin-Induced ThrombocytopeniaNew England Journal of Medicine, 2015
- Reexposición temprana a heparina durante el trasplante cardiaco de pacientes con trombocitopenia inducida por heparina y asistencia ventricularRevista Espanola de Cardiologia, 2015
- Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopeniaClinical Chemistry and Laboratory Medicine (CCLM), 2014
- High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin‐induced thrombocytopenia antibodiesInternational Journal of Laboratory Hematology, 2013
- Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patientsHaematologica, 2011
- Effects of Argatroban Therapy, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced ThrombocytopeniaChest, 2006
- Heparin-induced thrombocytopenia (HIT)Thrombosis and Haemostasis, 2006
- Heparin-Induced Thrombocytopenia in PediatricsSeminars in Thrombosis and Hemostasis, 2001